Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL869519 | 0.74 | POLB (0.56) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL31675176 | 0.74 | POLB (0.56) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL18834394 | 0.71 | ALDH1A1 (0.46) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL4079229 | 0.67 | ALDH1A1 (0.58) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL10316754 | 0.65 | POLB (0.41) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL15865874 | 0.65 | POLB (0.41) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL2226978 | 0.65 | ALDH1A1 (0.55) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL23986724 | 0.64 | ALDH1A1 (0.37) | ALDH1A1TDP1POLBSLC2A1NPSR1 | |
| SCHEMBL12858698 | 0.63 | ALDH1A1 (0.57) | ALDH1A1TDP1POLBSLC2A1MCL1 | |
| SCHEMBL15199501 | 0.63 | POLB (0.45) | ALDH1A1TDP1POLBSLC2A1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3033066-B1 | POLYUREA OR POLYURETHANE CAPSULES | INT FLAVORS & FRAGRANCES INC (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-3894381-A1 | DODECA-4,8,11-TRIEN-1-OL AND ITS USE AS AROMA CHEMICAL | BASF SE (DE) | 2021-10-20 | — | — | EP | disclosed |
| EP-3802758-A1 | 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-04-14 | — | — | EP | disclosed |
| WO-2020120469-A1 | DODECA-4,8,11-TRIEN-1-OL AND ITS USE AS AROMA CHEMICAL | BASF SE (DE) | 2020-06-18 | — | — | WO | disclosed |
| WO-2019224373-A1 | 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2019-11-28 | — | — | WO | disclosed |
| EP-3464224-A1 | PROCESS FOR PREPARING 2,3-UNSATURATED ALCOHOLS | BASF SE (DE) | 2019-04-10 | — | — | EP | disclosed |
| CN-107530297-A | Microcapsule composition with high performance | 国际香料和香精公司 | 2018-01-02 | — | — | CN | disclosed |
| WO-2017211784-A1 | PROCESS FOR PREPARING 2,3-UNSATURATED ALCOHOLS | BASF SE (DE) | 2017-12-14 | — | — | WO | disclosed |
| CN-104560398-A | Hybrid fragrance encapsulate formulation and method for using the same | INT FLAVORS & FRAGRANCES INC | 2015-04-29 | — | — | CN | disclosed |
| CN-104546518-A | Stable, flowable silica capsule formulation | INT FLAVORS & FRAGRANCES INC | 2015-04-29 | — | — | CN | disclosed |
| US-7846886-B2 | Mixtures of unsaturated macrocyclic epoxides as odoriferous substances | SYMRISE GMBH & CO. KG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-20090305928-A1 | Mixtures of Unsaturated Macrocyclic Epoxides as Odoriferous Substances | SYMRISE GMBH & CO. KG (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090175812-A1 | Novel Skin Lightening Agents, Compositions and Methods | CONOPCO, INC., D/B/A UNILEVER (US) | 2009-07-09 | — | — | US | disclosed |
| EP-1603527-B1 | TERPENOID FRAGRANCE COMPONENTS STABILIZED WITH MALONIC ACID SALTS | UNILEVER PLC (GB) | 2009-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305928-A1 | Mixtures of Unsaturated Macrocyclic Epoxides as Odoriferous Substances | OXER1, OR10J3, OR51E2 | ALDH1A1 121/4885TDP1 4763/4885POLB 1158/4885 |
| US-20090175812-A1 | Novel Skin Lightening Agents, Compositions and Methods | C1R, CBR1, OXER1 | ALDH1A1 830/4885TDP1 3311/4885POLB 1536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.